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Acute PM2.5 Exposure and Medicare Hospitalizations in Texas

Abstract
Rationale: Fine particulate matter (<2.5 um), or PM2.5, and Ozone has been linked to a number of respiratory
and cardiovascular conditions and is a known trigger for acute events. Though previous studies have addressed
these correlations, few have examined PM2.5’s acute effects on inpatient admissions and health care costs, by
utilizing narrower time intervals than other research projects.
Objectives: To identify whether trends in hospitalization spending in short time-intervals is associated with
PM2.5 measures, and to create a predictive model for spending based on two major categories of outcomes:
selected CV conditions and respiratory conditions known to be associated with PM2.5 exposure that we will
identify by Medicaid charge codes. We also attempt to model inpatient admissions altogether as an alternative
outcome.
Methods: We link Medicaid charge information for all procedures in Texas to daily air-quality data sourced
from 63 EPA sites in the state and fit a longitudinal mixed model to extrapolate costs and risks of additional
inpatient stays due to respiratory conditions from particulate matter readings. Outcomes are identified by APRDRG codes listed in the Blue Ribbon Medicaid set and exposure measurements are sourced from the EPA’s
monitoring stations’ data mart. Our study covered September 2010 to August 2011. We also adjust for other
potential covariates and exposures like Ozone in later models.
Measurements and Main Results: We find positive association between environmental PM2.5 and healthcare
spending. Our simpler multilevel linear model gave us these cost estimates: rates of Respiratory and CV
charges to Medicaid increase $3.95 million dollars to each increase of ug/m^3 in PM2.5, under our simplest per
capita model. A more sophisticated secondary-model states that ozone is the more significant predictor of
costs/charges, and one of our models produced an annual $600,000 increase per additional 0.01 ppm of
exposure over the year. We also find that modelling counts of hospitalizations fit our model better as an
outcome.
Conclusion: The models suggest a positive association between Medicaid spending and PM2.5 or Ozone
exposure. These measurements can be utilized to predict morbidities based off of air quality, as well as estimate
the impact to Medicaid in terms of its financial strain. This information can be utilized in resource allocation in
terms of hospital staffing and local medical needs, as well as on larger scale, aiding policy decisions.
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Introduction
Air Quality and fine particulate matter exposure affects peoples’ respiratory and cardiovascular health.
His impact can be measured in admission rates and increases in medical costs. On an aggregate level, the CDC
estimates that, inducing costly conditions like asthma that costs the US up to $56 Billion per annum* (CDC
2011). This increase in costs is in part due to hospital/ER admissions, and for our purposes we will isolate the
spending trends in Medicaid-dependents of Texas, whose 3.5 million members account for $25 billion in annual
healthcare spending. Regulatory authorities in Texas consider PM2.5 level at acceptable at 12 μg/m3 average
daily exposure over the year, compared to the 10 ug/m^3 standard set by the WHO and other international
standards (WHO 2015). In the context of guiding future policy decisions, this type of research might provide
some sort of financial guideline for resource allocation and policy reconsideration.
Background and Prior research
Although previous studies have found an association between air quality and health care spending, these
studies had some limitations. Some analyses and bundled air measurements by month, which provided poor
temporal resolution in modeling fine responses to air quality changes, and the resulting economic burden. Some
analyses established a relationship between conditions and particulate matter in for a narrow number outcomes,
like only measuring mortality’s association without accounting for nonlethal morbidities (Katsouyanni 1998).
Looking at all hospital treatments at the daily level might provide better resolution to find more subtle
associations.
Research has been executed utilizing Medicare charge data joining datasets with EPA exposure data to
do analyses over a wide geographical area, with separate models for different regions, (Peng 2008). These
models tracked and measured hospitalizations compared to daily readings aggregated to the county level,
providing both a more accurate assessment of the burden of the disease, as well as its geographical distribution.
” (Peng 2008). Though originally evaluating PM10 exposure, larger particles that are more likely to be filtered
out and caught before doing damage, they found that after controlling for PM2.5 the PM10 exposure associated
become much more attenuated, and that the ultrafine PM2.5 particles were more likely to be causally associated
with admissions for respiratory and cardiovascular diseases. These authors convincingly demonstrated higher
Risk Ratios in respiratory and cardiovascular conditions in geographical areas with higher ambient particulate
matter. Other analyses undertook similar analysis but utilizing indirect measurements like distance from roads
as a proxy over direct air readings, requiring yet another set of assumptions that affect the precision of
individual exposure estimates (Gilbert 2003).
Contribution
Through monitoring daily air-readings and inpatient admissions to the zip-code level, this paper adds to
this literature by using more granular geographic areas to measure these associations. I will refine the
geography of exposures by linking environmental air quality measurements to patient rather than hospital data.
Also, rather than simply tracking risk ratios, I will provide a predictive estimate to the social burden of these
direct costs—by providing cost estimates for the medical procedures for conditions that are generally accepted
to be associated with PM2.5, and how it is influenced by daily AQI environmental readings.
This analysis is restricted to the state of Texas and uses patient level charge data to estimate fluctuations
in spending on cardiovascular and respiratory diseases and how it is associated with changes in air quality. By
utilizing the EPA’s daily PM2.5 readings from 58 measuring stations in Texas (data from the AIR QUALITY
SYSTEM DATA MART database spanning years 2010-2014), we can get a finer level of geospatial AND
temporal precision that is required when measuring acute responses and costs.
These measurements can be utilized to predict morbidities based off of air quality, as well as estimate
the impact to Medicaid in terms of its financial strain. This information can be utilized in resource allocation in
terms of hospital staffing and local medical needs, as well as on larger scale, aiding policy decisions.
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Table 1: Descriptive Information of our overall Texas Medicaid Sample and Associated Measurements
SITE:EPA
1
2
3
4
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
24
26
27
28
29
31
33
34
35
36
37
38
40
41
42
43
44
45
46
47
48
49
50

Number
CV/Resp
Charges*
110
155
1438
131
91
2
437
31
1123
38
6
2035
535
187
427
737
378
156
79
10
640
81
463
305
154
199
3536
13
206
554
196
852
3521
263
49
581
778
54
549
666
349
733
470
54

Mean Cost
per charge*
4608.79
5158.88
5074.01
4673.9
3835.7
4120.83
3435.05
3562.31
3846.65
3682.29
2670.4
6126.57
6091.99
7425.72
5606.25
3874.02
3668.06
4979.67
4264.88
3891.75
5560.48
4824.61
5126.45
9866.57
4809.52
6306.67
5866.44
4815.13
5015.63
5057.39
5188.51
4752.77
3191.47
3624.41
19533.52
3724.28
5098.99
6028.77
3823.5
4320.83
3661.44
5272.56
4282.16
4401.8

Std Dev
4049.1
6125.93
3454.16
11943.67
2690.48
2075.1
2202.77
1452.92
4565.87
2566.37
694.12177
9309.88
5528.57
11007.56
5549.68
3474.99
4296.19
7376.79
2152.24
2677.07
18306.18
3239.75
17496.44
13393.34
2690.86
16385.42
10604.19
1502.26
3412.86
10431.91
3782.59
4790.44
3178.75
3607.11
92830.08
2820.3
7388.92
7571.08
5487.15
9834.33
2566.51
18006.95
4075.77
3576.8

MeanPM*
9.966
9.632
10.114
9.847
10.563
10.237
.
6.637
10.867
10.987
6.664
11.104
10.130
.
8.754
10.216
9.246
8.452
9.254
10.124
10.857
12.450
8.618
9.641
11.570
11.386
10.951
12.255
10.616
10.792
9.408
10.625
11.510
10.318
9.140
8.644
10.125
10.768
9.507
8.736
10.274
12.944
9.950
10.096

Std
Dev
5.124
5.149
5.063
4.973
5.220
5.196
.
4.676
5.266
4.552
5.525
3.551
4.065
.
4.551
5.532
4.361
4.095
3.841
4.161
5.194
7.660
4.362
3.945
4.820
4.400
4.229
4.234
4.299
4.545
3.498
7.681
5.603
6.288
3.966
4.220
4.027
4.674
6.355
3.883
6.028
5.397
4.299
4.497

Total Cost
CV/breathing*
$506,966.90
$799,626.40
$7,296,426.38
$612,280.90
$349,048.70
$8,241.66
$1,501,116.85
$110,431.61
$4,319,787.95
$139,927.02
$16,022.40
$12,467,569.95
$3,259,214.65
$1,388,609.64
$2,393,868.75
$2,855,152.74
$1,386,526.68
$776,828.52
$336,925.52
$38,917.50
$3,558,707.20
$390,793.41
$2,373,546.35
$3,009,303.85
$740,666.08
$1,255,027.33
$20,743,731.84
$62,596.69
$1,033,219.78
$2,801,794.06
$1,016,947.96
$4,049,360.04
$11,237,165.87
$953,219.83
$957,142.48
$2,163,806.68
$3,967,014.22
$325,553.58
$2,099,101.50
$2,877,672.78
$1,277,842.56
$3,864,786.48
$2,012,615.20
$237,697.20
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51
52
53
54
55
56
57
58
59
60
62
63

581
198
150
182
723
242
1170
376
1039
490
712
585

5026.23
4115.11
3295
4495.89
4663.74
5190.72
5354.69
7092.81
6246.86
6567.42
3441.29
4086.27

4041.3
2443.61
2984.02
10712.26
12117.53
5544.81
8681.7
20000.42
7400.63
44787.68
5867.9
5183.53

TOTAL

.
9.268
.
9.705
7.094
.
10.488
9.614
9.612
8.445
12.235
7.991

.
3.820
.
4.184
4.027
.
4.142
4.456
4.885
4.490
6.064
3.900

$2,920,239.63
$814,791.78
$494,250.00
$818,251.98
$3,371,884.02
$1,256,154.24
$6,264,987.30
$2,666,896.56
$6,490,487.54
$3,218,035.80
$2,450,198.48
$2,390,467.95
$146,729,448.97

SITE:EPA represents the catchment zone generated with an EPA monitoring site with a center. Blanks are sites
where we were not able to derive information, and were shuffled into the next closest site in subsequent steps.
Amongst the 13 sites we ended up discarding, 5 were discarded due to sparse air readings (strikeout).

TABLE 2: Data Overview-Aggregate Data
Value ± SD
DATA
SOURCE
Mean
49437.14 ±
charges
65628.48
Mean
Ozone
(ppm)
Mean
8.9727 ± 3.0706
PM2.5
(ug/m^3)
Mean #
62699 ± 84809
Medicaid
Mean Pop

429217 ± 581472

p-value
P<0.0001*
P<0.0001*
P<0.0001*
---

P-values derived from ANOVA for tests comparing one EPA-Site Catchment area’s weekly readings to another,
suggesting fundamental differences caused by hidden secondary covariates between zones.
*p-values are lifted from ANOVA comparing by groups organized by EPA-site, and are significant on a p <
0.05 under a Bonferonni correction.
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Datasets and Sources
We utilized 2011-2012 Medicaid charge information from the Texas ‘Blue Ribbon’ dataset as our source
of healthcare cost information and place of residency associated with each patient. We utilize this information
and geocode cases of asthma/COPD to the nearest EPA catchment site. These places of residency are paired to
one of the three EPA 63 monitoring sites which offer daily* average mean readings of PM2.5 (particulate
matter) exposure, which we utilize as an environmental proxy for an individuals’ exposure.
In this model, we have divided Texas into 55 geographic areas (after dropping 8 sites due to data
scarcity), whose centroid is one of the associated EPA sites. All respiratory cases in the blue ribbon set are
paired with one of these geographic locations, contributing to that sites’ daily repeated measures as an outcome
(Table 1). We utilize EPA sites’ readings for the date, utilizing the 3 day moving window average of PM2.5 for
that site.
TABLE 3: Data Overview
DATA
Description
SOURCE
BLUE
SOURCE OF MEDICAID
RIBBON
DATA
EPA-QS

Daily/Weekly PM2.5
readings

Census

Population controls useful
for establishing rate
outcome.
Geocoding/geoprocessing
Our link between our Blue
Ribbon Set and our EPA
set.

Centroid
Locations

Relevant variables
CHARGE Costs, Area
Code associated with
residency, Diagnosis
Related group
Longitude/latitude of
measuring sites, pm2.5
level
Population per geographic
area
Longitude and Latitude
associated with area codes.

Blue Ribbon Project (HCUP data)–Our charge information and proxy for ‘direct’ respiratory costs was
sourced from the Texas-based Medicaid dataset managed by state Health and Human Services. Out dataset
contains two years’ worth of charge information from 2011-2012, identified by DRG. However, unlike other
datasets it is lacking in SES type information.
We were able to isolate certain categories of charges from form information. The dataset categorized the
type of inpatient admission via APR-DRGs (2009), looking at known respiratory outcomes from the literature
(Chung 2005).
EPA-AIR QUALITY SYSTEM DATA MART DATABASE: The source of air quality measurements are
collected from the EPA monitoring stations and downloaded rom their Air Quality System Data Mart system,
sampled from 2010 to 2014. The AQS database-provided specific daily averages taken at variable intervals
across the year. Data was provided in the form of average PM2.5 and Ozone readings for the day. It includes
specific measurements by type of air pollutant. We utilized readings from the 58 air quality monitoring stations
in Texas. We also drew the boundaries of our catchment zones from each EPA-site longitude and latitude. The
centroids of area codes are assigned to the nearest EPA Air quality site as its landmark, and all the area codes
designated to the same EPA monitoring site are assigned to the same zone/catchment area.
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Census Data: 2010 Census information helped estimate the population of each catchment area by ZCTA
(analog for zip code) and a ZTCA crosswalk file that allowed us to translate raw area codes to the census
ZCTAs. By combining these datasets we can generate per-capita cost figures and hospitalization rates. An open
source population centroid dataset was utilized to translate/mask the individual’s area code to a ‘zone’ of these
using the SAS 9.4 package Geocoding features to receive longitude and latitude data, to filter only for datasets
close by to the EPA or state air-quality monitoring stations.
We repeated this process for the different OZONE monitoring stations also derived from the AQS EPA
system, which had its own sets of sites and longitude and latitude information.
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METHODOLOGY: DATA CATCHMENT/ SELECTION CRITERIA

Methods: Measurements of Exposures and Outcome Identification
Like previous studies we utilize environmental measurements closest to individuals’ place of residence as a
proxy for Medicaid patients’ exposures to PM2.5 or ozone. We did not account for indoor exposures or personal
air monitoring readings. This method, however, gave us the advantage of being able to fit longitudinal repeatedmeasures models to elucidate the relationship between spikes in PM2.5 air concentration and causally-linked
health outcomes like asthma and COPD on a very large scale.
Outcomes were identified from the hospital blue ribbon dataset using commonly known 2011 APRDRGs (diagnosis related groups) that are indications of the type of condition a patient is admitted under. From
the literature we focused on respiratory admissions whose primary diagnosis was Asthma, COPD, Respiratory
Inflammation, pulmonary embolisms, Bronchiolitis, all conditions whose associations with PM2.5 are well
documented (Dominici 2006). We looked up codes with the accompanying data-dictionary for the Medicaid
charges that specify the type of primary condition the patient was afflicted with.
We also focused on certain cardiovascular conditions whose relationship to acute PM2.5 is also supported
within the literature (CDC 2011). Heart Failure, Cardiac Arrest, myocardial infection, along with a few other
acute conditions have strong positive associations with localized PM2.5 exposure (Talbott 2014). We also listed
some conditions associated with Ozone exposure, as ozone is associated with our primary outcome asthma. The
rest of the exposures are listed in Table 3 (Lin 2002).
We subset outcomes for more refined analysis based on Respiratory Only categories (left column, Table 3),
Cardiovascular Conditions (right column, Table 3), and all-combined. In increase the percentage of cases, as we
would’ve ended up with many strata with zero values, we ended up utilizing the combined conditions listed in,
all associated with PM2.5 (Karr 2006).

Table 4: Medicare-DRG Classifications used to identify charges for conditions associated with PM2.5
Respiratory Conditions:
Cardiovascular Conditions
Pulmonary edema
Myocardial Infarction
Pulmonary embolism
Heart Failure
Major Inflammation
Cardiac Arrest
Bronchiolitis
Angina Pectoris
COPD
Cardiomyopathy
Asthma
Cardiac Arrhythmia / Hypertension
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Methods: Geocoding and Group Allocation
Allocation of individuals was done utilizing charge data from the Blue Ribbon file. The dataset had a zip
code of home residence that we were able to utilize. From this we are able to pair people by area code to their mean
weighted population centroid location via longitude and latitude. This is similar to the method employed by
previous studies linking hospitals to the county level measurements (Peng 2008), and likely provides a more
realistic measurement than others that utilized even more indirect measurements like distance from roads as a
proxy.
Geocoding of study sites was executed by taking longitude and latitude measurements for all 63 EPA air
monitoring stations and utilized them as the center of circular zones that would be utilized to allocate charges to.
With fields provided by both datasets, we can geocode the individual charges to specific EPA sites by min distance.
Map them via the area-code information provided by Blue Ribbon charge dataset, pairing individuals to an EPA
monitoring site as its anchor point. Since we only had area code resolution, we utilized a publically available meanpopulation centroid dataset.
SAS handled all geo-coding measurements, utilizing built-in operators like a geo-distancing function to
calculate distances. We determined which EPA site most representative of the individual patients’ exposure by
calculating the closest site. For each of the 400k observations available in the Blue Ribbon charge data, SAS
calculated distances (from the patient’s area code centroid location) to an array of 58 longitude-latitudes associated
with the air monitor locations.
In effect, our model treated each geographic circle as the lowest level of measurement for our outcome
(hospitalizations/spending per site), utilizing the monitoring station as both the center and the source of that area’s
daily-ish PM2.5 / AQI readings.

Figure 1: Aggregated Catchment Zones.
A map of ZCTAs (smallest borders) with each color representing a cluster of catchment zones for readability.
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Figure 2: Structure of Aggregated Data

EPA-Monitoring Area
1
2
3
…
63

Daily Counts from September 1- August
31st
Day 1
Day2
Day3
…
obs1 (= COST +
PM2.5)
Obs2 

Day365
Obs365

…
OBS 1

Obs2

Obs365

*Structured for hierarchical repeated measures analysis.
Individual charge data was distilled to number of counts (/or cost accumulated) for respiratory conditions per day,
along with a paired pm2.5 reading from that specific EPA monitoring site/catchment area.
Data Imputation:
The data was complex: the 63 EPA sites were not homogenous in the amount of readings a year available.
Due to wanting to properly utilize all charge information available and not just drop the hospital information
associated with missing air-reading days, we utilized splining and imputation methods. Regression Splines with
Longitudinal Data was the basis of our imputation methods.
Also utilized a simpler linear-spline method via SAS.
These modeling and estimation procedures had been utilized previously for similarly structured data to justify our
use of LOESS or interpolation for mixed data (Jo 2007). We fit these measurements as the primary identifier when
we were missing a true reading.
We had to drop 8 sites due to the lack of charges. Another 10 zones were also dropped because of scarcity of
air data and were allocated to the next closest source. The variations in distance of the population to its matched site
might provide some sort of measurement bias. We did not utilize imputation for the ozone records, as fortunately,
though there were fewer sites, had daily readings for all of them.
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Methods: Modeling
We executed a basic descriptive statistical analysis for an overview of the air-readings and charge
information associated with each catchment area (Table 1) along with an ANOVA test comparing differences in
weekly readings between zones.
Model Description
Primarily, all our models are mixed longitudinal models with repeated measures. We treated each
catchment area associated with an EPA site as the smallest individual subject that provides the mean PM2.5
reading for the day aligned with the daily medical expenses. These daily repetitive readings lend itself to
multilevel repeated measures model (Figure 2).
The Daily PM2.5 was our fixed independent variable component of our mixed model, as our primary
association of interest. The random effects components of our mixed model consists of a random intercept
associated with each EPA-catchment zone, to reflect the differences associated with each of the
microenvironments and populations housed within. As with other time series, we utilized a covariance structure
that was autoregressive, as subsequent air quality readings should not be independent from one another.
Outcomes and Exposure Estimation-imputation and the problem of time
Each EPA-site was the unit of analysis, with 3 outcomes: 1.) Cost associated with the day 2.) Number of
procedures executed 3.) Charge amounts associated with the inpatients for the day. Daily PM2.5 and Cost
calculations as the nested, repeated measurement. We also remodeled different outcomes based off of binned,
aggregated value with weeks as the lowest unit of outcome/exposure. Table 2 and Table 3 illustrate the various
model fits and time frame of exposures and outcomes that we utilized.
Delving into the literature, previous studies also considered multiple models for PM2.5 exposure (Peng
2008). Some papers and models associated the same day air quality readings with the fixed lag-time models, more
traditional, and with the correlation structure previous values still have some sort of influence on the model. Peng
and Bell’s 2008 paper with Medicaid data utilized various lag-times, 0 day, 1 day, 2 day, while we will utilize a 3
day rolling average window. Some papers emphasize a model of gradual sensitization before an asthma attack
(Lin 2002). I wanted the model to capture a larger window of exposures than a single lag-time(especially since
acute can be triggered by an ‘accumulation’ consistent high levels of PM exposure), and especially given my
imputation methods, a 3 day moving average is appropriate so that results will ‘dilute’ the effect of missing an
extra outlier. However, this will likely drag associations closer to the null. Later, through data aggregation we
utilize a weekly average to measure ozone and PM2.5 exposure.
Model Progression
We will fit multiple models, simple outcomes isolating PM2.5 and later fits that include known covariates
that affect our outcome like Ozone. We will also try alternative time-frames in terms of exposure measurements:
not only are we going to utilize three day moving averages, but we will estimate our outcomes using broader
binned weekly measurements of PM2.5 and ozone.

Wei 11

Results and Estimates
The statistically significant p-values derived from ANOVA for tests comparing one EPA-Site Catchment area’s
weekly readings to another, suggesting fundamental differences caused by hidden secondary covariates when
comparing different areas of the state in Table 2. Of course, this ignores some of the temporal component, but is
useful for understanding that there is indeed a difference in the effect of air quality between groups and spending.
The statistically significant p-values derived from ANOVA suggest differences in average per capita costs and air
exposure.
Daily PM2.5 as a Linear Predictor of Actual Amount Paid:
Table 5 contains the parameters to calculate amount of money associated with each increase in ug/m^3 in our
mixed model. Models have varying outcomes (by site by site or per person, which enables different controls) and
(varying lag times and measurement intervals) for the independent variable measurements. In our mixed model with
a 3-day rolling average of PM2.5 ambient concentration as a predictor, we were able to find statistically significant
values for our daily costs as an outcome per geographical site(p<0.001), and marginally significant outcome with
the per capita outcome (p=0.0737, Table 5). This true cost outcome is the actual amount paid out by Medicaid for
the hospitalizations in the Blue Ribbon set. We find that site specific estimates produce an estimated
50 ∗ 365 ∗ 515.68

$

= $9,411,160, in additional state Medicaid spending per additional year.

Utilizing the individual per capita spending as an outcome and again extrapolating these results to a statewide
estimate, a 1 PPM increase in annual PM2.5 exposure to the Texas population(25MM) is estimated to have this
economic impact:
25.26MM People *365* 0.0004190

$

= $3,863,138 for Texas over the year.

TABLE 5: Model Parameter for mixed model with TRUE-Cost as outcome.
ModelOutcome
Exposure
$
PM2.5-B1
Outcome
Time Frame
Window
$ per site

Per day

Covariates

p

3-day rolling
515.68
*
<.0001
average
PM2.5
$ per site
Per week
Weekly
158.09
0.2466
*
Average
$ per capita
Per day
3-day rolling
4.190E-4
0.0747
*
average
+local pop
PM2.5
$ per capita
Per week
Weekly
0.01217
<.0001
*
Average
+local pop
Parameters to calculate amount of money associated with each increase in ug/m^3Mixed Linear Models with
Repeated Measures. Models have varying outcomes (by site by site or per person, which enables different controls)
and (varying lag times and measurement intervals) for the independent variable measurements.
*Adjusted for Census Population in catchment Area, and proportion of Medicaid participants
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Daily PM2.5 as a Linear Predictor of Charges:
TABLE 6 shows parameters to calculate amount of charges, not amount paid, associated with each increase in
ug/m^3 in our mixed linear models. Models have varying outcomes (by site by site or per person, which enables
different controls) but not have fixed weekly exposure variables for the independent variable measurements.
In our mixed model we had fit PM2.5 concentration, measured in ug/m^3, against the daily outcome of hospital
charges. It is a secondary measurement subject to inflation of costs and variance. But unlike ‘amount paid’, charges
however are not negatively biased downwards by payments still due or costs that have been waived. We utilized an
alpha =0.05 to test against the hypothesis that a predictor included is statistically significant (P<0.0001). We found
that per site, a 1 ug/m3 increase in the 3-day window PM2.5 average would result in an estimated $1179 increase in
charges per day (Table 3). This parameter is statistically significant. Translated to: a number that covers the year
and the annual financial burden (as we have 50 catchment zones and 365 days in year):
50 ∗ 365 ∗ 1178.85

$

= $21,514,012.5

increase in Medicaid charges to Texas per 1ug/m^3 of PM2.5

We fit an alternative model which accounted for the population within each of our designed catchment zones, and it
produced a positive linear association between pm2.5 and Medicaid charges (P<0.0001, Figure 3). Again,
translating these results to a statewide estimate, a 1 PPM increase in annual PM2.5 exposure to the Texas
population is estimated to have this economic impact:
25.26MM patients *365* 0.002664

$

= $24,892,416

for Texas over the year.

Alternative Models: Weekly PM2.5 and Ozone as a Linear Predictor of Amount Paid:
Table 7 contains Mixed Model regression parameters of alternative fits weekly exposure averages for models with
Ozone and PM2.5. Models have exposure variables measured as a weekly average for the independent variable
measurements, but differ. Additional covariates are illustrated by the plus sign. Also transformed outcome variable
by taking square root of the per capital cost. We find that our mixed model with $ Per Capita Per Week as an
outcome, when fixed with a time effect, had no significant air exposure parameters, with PM2.5 having a p-value of
0.84 and Ozone at 0.15.
In our model with $ per capita per week as an outcome (Table 7), each 1ug/m3 increase in PM2.5 results in a
$2.181E-3, and each 0.01 increase in ppm results in a $0.024503 per capita, which roughly translates to $612575.
From our model, we took the square root transformation of $ per capita per week, and found that PM2.5 is a nonstatistically significant predictor, but ozone is borderline significant (p=0.0582). For each 0.01 increase in ozone
ppm increases square root per-capita cost per week by 0.006871, which translates to an additional $621824 to
Texas Medicaid a year.
Count as an outcome:
We also modelled count as a secondary outcome. We find that both PM2.5 and Ozone are statistically significant
predictors at p=0.0334 and p<0.0001 respectively. For each increase in ug/m^3, the weekly per capita
hospitalization count increases 0.002181, and for each 0.01 ppm increase in ozone, it is increased by 0.005351.
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Figure 3: Prediction estimates daily and weekly exposure outcomes.

Clockwise from top left to right, daily per capita predicted costs are charted against actual costs, daily costs per
catchment area predicted cost vs Actual readings, Predicted weekly costs per capita vs actual, and Predicted weekly
region costs vs actual ones. PM2.5 is the only exposure variable.
Top row displays our daily readings for our outcomes. Bottom row utilized our weekly binned averages.
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Figure 4.Weekly per Capita
Count Outcome, square root
transformed. Predictive Models
versus actual data.
Our mixed model generated a
count of hospitalizations per
capita. Two sites were chosen for
readability. The shaded blue line
is the predicted values, and the
colored area is the 95%
confidence interval
The red series is a splined fit of
the actual outcome variables,
detecting a series of cost
measurements.
Note: Left axis refers to the
prediction. Scales are not equal
and just meant to illustrate trends.
Covariates include PM2.5 and
Ozone in these model
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Figure 5: Square-root
transformed per-capita
spending and its predictive
model.
Depicts the predicted mean of
square root of cost per capita per
week in sites, compared with the
raw, tabulated cost per capita.
These costs are measured by
actual amount paid. Observations
are binned by weekly units.
The blue series represents the
models prediction along with the
95% CLM.
The red spline fit are the actual
cost readings per capita per week.
Model includes both PM2.5,
Ozone.
Note: Scales are not equal and
just meant to illustrate trends.
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TABLE 6: Model Parameters with Charges as an Outcome
ModelOutcome
$
per site
Per day
$ per
person
Per Day
$ per
person
Per Week

Exposure
Window
3-day AVG
PM2.5
Interpolatio
n
3-day AVG
PM2.5

PM2.5-B1

Weekly
Average

2.181E-

1178.85

Covariates

p

*

<.0001

*

<.0001

*
+ OZONE

<.0334

$

2.664E-3
$

3

$

Parameters to calculate amount of money associated with each increase in ug/m^3Mixed Linear Models with
Repeated Measures. Models have varying outcomes (by site by site or per person, which enables different controls)
and (varying lag-times and measurement intervals) for the independent variable measurements.
*Adjusted for Census Population in catchment Area, and proportion of Medicaid participants.
TABLE 7: Model Parameters with Ozone Fits
Model Exposure
Covariates
Outcome
Window
*
$ per capita
Per Week
$ per capita
Per Week
$
person

Weekly
Average
Weekly
Average
Weekly
Average

+ Ozone
+Ozone
+Fixed Time
Covariates
+ Ozone

PM2.5
}{

Ozone
-

2.181E-3
(P<.0334)
0.000573
(0.8462)
0.008587
(p<.0001)

2.4503
(p<.0001)
0.8080
(p=0.1506
)
4.0555
(P<.0001)

-0.00042
(p=0.7428
)

0.6871
(p=0.0582
)

Per week
$
person

Weekly
Average

+Ozone
+Fixed Time
Covariates

Per week
Mixed Model regression parameters. Models may have varying outcomes (by site or per person, which enables
different controls) all have weekly exposure variables for the independent variable measurements. Additional
covariates are illustrated by the plus sign. Transformed outcome also present in last rows. Models refer to regression
fits in Figure 7
*Adjusted for Census Population in catchment Area, and proportion of Medicaid patients.
}{ Parameter estimate measured in

$

- Parameter estimate measured in ppm for Ozone
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Figure 6- Per-week count of
inpatients predicted controlling
for OZONE + Fixed Time
Effect
The following three graphs
describe the Per Capita Number
of hospitalizations vs the
Predictive Model. Again, scales
are different and meant to
highlight the predictive validity
association with our major
covariates. Major independent
variables in this predictive model
include both PM2.5 & OZONE,
as well as a fixed time effect.
The blue series represents the
models prediction along with the
95% CLM.
The red spline fit are the actual
cost readings per capita per week.

Wei 18

Figure 7-Model Prediction of
Per-Week Per-Capita costs
with OZONE + Fixed Time
Effect
The following three graphs
describe the Per Capita Cost vs
the Predictive Model. Again,
scales are different and meant to
highlight the predictive validity
association with our major
covariates. Major independent
variables in this predictive model
include both PM2.5 & OZONE,
as well as a fixed time effect.
PM2.5 is not significant at all in
the model.
The blue series represents the
models prediction along with the
95% CLM.
The red spline fit are the actual
cost readings per capita per week.
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Figure 8-Square Root
Transformed Weekly Cost Per
Capita. With OZONE + Fixed
Time Effect additional
covariates
The following three graphs
describe the Per Capita Cost vs
the Predictive Model. Again,
scales are different and meant to
highlight the predictive validity
association with our major
covariates. Major independent
variables in this predictive model
include both PM2.5 & OZONE,
as well as a fixed time effect.
PM2.5 is not significant in this
model (Table 7) but OZONE is
marginally significant.
The blue series represents the
models prediction along with the
95% CLM.
The red spline fit are the actual
cost readings per capita per week.
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Discussion

Estimating financial impacts:
The project had a number of different models designed with a different purpose in mind. We began
studying costs by utilizing the charge amounts as a proxy outcome, as some bills were left unpaid. But due to
the extreme ratio of actual-cost:charge that exist in Texas (as high as 100:1), it resulted in an over dispersion of
values and an almost certain overestimation of costs. Instead we elected to utilize the ‘amount paid’ as an
outcome which is far more accurate, and actually reflects the amount of money going to providers.
In Figure 3, we have mapped out the cost calculations and have estimates in the PM2.5 parameter
$20,000,000/year range in Medicaid charges alone that can be attributed to a PM2.5. And under the guise of
evaluating the cost of the US’s more lax standards, at 12 ug vs the 10 ug recommended by the WHO, this
translates to a $40,000,000/year increase to Medicaid. However, this model can actually underestimate
cardiovascular + respiratory costs associated with our gas exposures, as we are only utilizing the primary
diagnosis codes in the Blue Ribbon’s Medicaid charge information, leaving out secondary conditions that may
contain some of the conditions of interest listed out in Table 4.
For our later models we decided only to focus on the binned, weekly exposures instead of taking
advantage of the daily outcomes that we could generate in our model. The day-to-day level of resolution
generated some ‘noisy’ graphs and slight over dispersion for the lower descriptive values, and the weekly
exposures actually circumvented some of that. These estimations provided far more conservative estimations in
the $600,000 range per additional increase of ug/m^3 in PM or 0.01 ppm increase in ozone.

Rationale for multiple model generation:
We have two broad classes of models that we fit: a predictive model that attempts to isolate the effect
of PM2.5 (Table 4) and a better fitted descriptive model (Table 5). We found a statistically significant
relationship between PM2.5 exposure and hospitalization costs, after controlling for the population size of each
catchment sector and the proportion of Medicaid enrollees in the area. We found a similar proportion of
Medicaid recipients in all areas. The main reason we did not utilize time fixed effects in our model is to
attempt to isolate the effect of the contaminants. Though the predictive model would definitely perform better
with the fixed time effects, there is a danger of over-fitting; what might actually be attributed to the variation in
gas exposure might be reflected by the time effect, eliminating the chance of detecting a subtle effect of air
quality on acute conditions/hospital admissions. As well, over fitting would weaken the models’ usefulness and
applicability to other years as seasonal disruptive events might account for many of the ‘fixed effect’
intercepts.

Validation of our predictive model and modelling progression:
Figure 3 output listed the expected change in cost per additional unit of PM2.5 exposure in a 3day
moving window. Plotting diagnostics like a residual plot and QQplots (not pictured) we noticed a
heteroscedasticity and an over-dispersion when looking at lower predicted values against the residuals. There is
a fan shape with variation highest at the lowest predictive values and becoming. It does look relatively
normally distributed otherwise despite the shifting variance. Modelling count data as an outcome (or the
number of hospitalizations or medical charges themselves) in Figures 4, 6 actually solves some of this
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heteroscedasticity and the residual plot was much improved; likely because we used charges as our cost
outcome, which has a huge variation in values and in inflation (cost to charge ratios can balloon from 2x to
orders of magnitude greater). Another solution was transforming our outcome variable by taking the square
root, which turns out to be effective. As mentioned previously, binning results by weekly exposures and costoutcomes produced less noisy graphs, as in figure 3, and we adjusted exposure levels to be weekly means to
reflect the changes to our measurement outcome from the daily values.
In regards to the more parsimonious models, notice that Figures 3-6 have predictive models that mimic
the shape of cost or count trends, if not the proper magnitude. This problem might be due to some seasonal
effect that we’re not monitoring, or some other time-dependent covariate that we do not have data on (possibly
another air exposure, or climate conditions that might affect exposure or the manifestation). In subsequent I
hope to integrate temperature readings which likely affect rates of respiratory/cardiovascular inpatient
admissions (Peng 2002).
The predictor preserves the correct directionality in change, but the predictions are often off in the
magnitude of change. Most likely our model does not capture all the necessary time sensitive-predictors;
either as confounders, or effect modifiers most likely. The bursts in amplitude at certain points give evidence
there is probably and synergistic effect-modifier that is lurking in the population.
Another possibility is that each individual has a specific environmental exposure threshold that when
crossed, greatly increases their risk in a non-linear fashion, though support for this model is tenuous according
to some research. As a result, we began to add on additional covariates like ozone effects and fixed-time
parameters (for exploratory purposes, year to year fixed time effects will differ and doing so might weaken the
applicability of my model to other years and other states). However, as a result the most accurate predictive
models, seen in Figure 7, has PM2.5 association almost completely attenuated, while leaving ozone’s
parameter marginally significant (p=.0582).
In Figure 7 we notice an interesting spike present in all the graphs at ~ Day 380. After checking
diagnostics to make sure it wasn’t an outlier or error in readings resulted in this odd artifact, we found that
there was a spike in costs and hospitalization in most of the regional catchment sites in this time frame. It was
not an error or artifact of the data; this sudden spike was evidence of a disruptive climate event. This date
translates to late January of 2011 and coincides with a major storm, the 2011 North American Blizzard. It was
a category 5 storm that hit North America and affected multiple states, even Texas, causing rolling blackouts,
water treatment shutdowns, and school district cancellations due to road hazards of ice and snow. Temperature
dropped into the single digits, halting infrastructure, (NWS 2011). It is noted that extreme changes in
temperature often trigger negative outcomes that include cardiac issues like heart failure and arrest, as well as
increasing the rate of asthma attacks (Huynen 2001). The effect on asthma and respiratory conditions is
twofold: not only does the cold induce exercise induced asthma through a mechanism of water/heat loss and
inflammation, but it also keeps children, an at-risk subgroup, indoors where there are more allergens (Medina
2006; Carlsen 2012).
Count as an outcome:
We also modelled count as a secondary outcome-and predictably, inpatient counts were easier to fit.
Prediction graphs are listed in figures 4-6, and notice how the variations in magnitude of spikes are not as
dramatic as in charges (which has an additional cause of variation caused by price differences between
conditions). We find that both PM2.5 and Ozone are statistically significant predictors at p=0.0334 and
p<0.0001 respectively. For each increase in ug/m^3, the weekly per capita hospitalization count increases
0.002181, and for each 0.01 ppm increase in ozone, it is increased by 0.005351.
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Potential Issues and Limitations:
There are fundamental issues with how we measure exposure and outcome that was caused by the
limitations of the data. As for our exposures: PM2.5 is a catchall, only referring to the size of particles and not
the composition. Previous research have noted that the specific source of PM2.5 affects the risk ratio for a
health outcome. And since we neither looked at the composition of the exposure nor modelled against single
outcomes, we could be missing out on cleaner correlations. Of course, these issues are due to sample size and
arriving at a zero-inflated over dispersed model, that might require some other modelling techniques like a
zero-inflated, mixed negative binomial regression , but it doesn’t quite preserve the strength ‘repeated’
structure, instead modelling each reading as a nested random effect of the individual (Liu 2007).
Our research relies on multiple assumptions in its design. One is that the bootstrapped values are
accurate; that the distribution of the 3.5 million Medicaid enrollees is distributed similarly to how charges are
distributed for the year. Our methods also assume that area code centroids an adequate estimate of peoples’
true residency location in regard to EPA-sites, and that these allocations to EPA-sites are adequate for
modeling purposes. However, there is the possibility that there’d be differential misclassification bias in terms
of environmental exposure: Those people who are living much further away from the nearest EPA site will
have values more likely to deviate from their true exposure. The distance from the nearest EPA site might also
harbor some confounding effects, as this population likely live further from major population centers or differ
in ways from the populations who live closer. We also assume two things in terms of exposures: The nearest
EPA-air quality site is an adequate measurement of environmental exposure of the place of residency, and that
the composition of particulate matter within the state is relatively constant from one monitoring station
delineated zone to another.
As well, we assume that the random effects component of our model enough to address multivariate
confounders: like variable proportions of SES, Age, Smoking (and other indoor exposures). We operated under
similar assumptions to “Statistical Analysis of Repeated Measures data” (Littell 1998). Variables I seek to
include in future analysis are temperature/ humidity, variables that are broadly considered significant modifiers
of cardiovascular AND respiratory outcomes (Carlsen 2012), and the specific components of our exposure
variable, PM2.5. As previously mentioned, the specific components of its composition was not considered state
to state, and the chemical profile will likely have differing effects. It is likely incorrect to broadly assume that
all PM2.5 has the same effect on the populace merely due to its similar size.
Our design also lends itself to the possibility of selection bias—the inpatient charges utilized were
derived from Medicaid only (particularly fee-for-service). Even when restricting my extrapolations and
conclusions to a Medicaid only group introduces possible confounding by multivariate factors as well (SES,
age distributions), since generally only poor, old, and infants comprise the main beneficiaries of Texas
Medicaid/CHIP and the distributions of these people amongst my sites might not be entirely
uncorrelated/independent. According to the Kaiser Health foundation, 4.6 million of the 25 MM residents of
the state are Medicaid beneficiaries (KFF 2013).
Also, selection bias might arise due to how we allocated EPA sites when we removed certain ones due
to missing data. Reallocation of catchment zone borders were caused by dropped EPA-sites that were filtered
out due to missing data and sparse measurements (regarding both charge information and environmental)
which would’ve led to excessive imputation and inaccurate models. Hopefully, the individuals that would’ve
been associated with these catchment are adequately represented by the next closest site and new catchment
zone we had paired them to. How this potential bias caused by our methodology and the lack of broader
population from which to derive charges from, including private and Medicare patients, remains unanswered
and require additional analysis.
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In response, the next time I might to get a broader pool of charge information, including the private
payers and Medicare charges, and have set catchment zones of a predetermined radius, similar to some of the
other studies on the subject (Peng 2008), while excluding those subjects who don’t live within the minimum
distance of one of the EPA measurement sites.
Finally, in terms of exposure assessment, utilizing environmental level measurements as a proxy for
individual level exposures lacks a lot of individual exposure information—particularly indoor exposure. We
assume that utilizing air monitoring stations are a good proxy for their outdoor exposure, but there is no
guarantee that they spend most of their time 1.) in the outdoors 2.) close to their place of residence. Another
issue pertinent issue when the nearest EPA air-monitoring site is much further than some patients to their
nearest site, leading to some questions of validity.
If I am restricting analysis to hospitals within a certain radius from certain air quality stations, I am
excluding a lot of potential data-points and possibly in a biased manner that will skew my results. Another
potential source of bias is the presence of specialty hospitals clustering individuals with the respiratory
conditions of interest. However, hopefully through randomization I can minimize potential confounding from
the multitude of potential modifiers. However, specifics information on measurement equipment for each site
were not available, leading to some unknowns as to the precision of the measurements. Despite these issues, I
feel there are useful impacts that might be gleaned through a single year cross-sectional relational model.
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Conclusions and Future Directions:
With additional data, I hope to adjust for additional confounders from the census as well as adjust for
additional exposure, using EPA sites. We can reevaluate the effect of other gasses like SO2 or ground level
ozone. As well, utilizing the census information once again, looking at population densities associated with
each area code and urban vs rural designations, we might be able to account for the difference in PM2.5
composition. Researchers mention that urban vs rural particulate matter exposure differ widely (Peng 2008).
Hopefully with these additional covariates we can improve the accuracy of our estimates and account for more
of the variation. There are also indirect burdens that are more difficult to quantify, due to elevated stress and
discomfort, and lost productivity. However, being able to quantify the financial and medical burden of this air
exposure in hard numbers is a fine start, especially in the light of policy standards for acceptable exposures and
when pushing for new public health initiatives.
Also I’d like to establish alternative models: like a moving average, hazard model that might prove useful
for medical organizations to forecast burdens to medical systems as a function of climate and air quality. As
well, utilizing more years’ worth of data I can undertake more model validation steps to determine predictive
power and refine the model. More years’ worth of data also enables more complex modelling techniques, by
allowing more ‘seasonal’ repetitions, enabling use of an auto-regressive moving average (ARIMA) forecasting
model to extrapolate future trends.
Policy makers and environmental regulators should consider the evidence about the associations
between cardiovascular/respiratory diseases with air quality when setting environmental standards for industry
or evaluating population level health interventions. The immediate costs of upgrading to ‘clean-air technology’
and other air quality interventions might be offset by the ‘hidden burden’ of pollution, opening up additional
potentially worthwhile investments for the public safety. Though I will be unable to monitor the indirect costs,
analyses such as this one can give a glimpse to a slice of the true costs of pollution.
In the meantime, these direct predictions can used in decision-making and policy adjustments, utilized in
relation to evaluate costs/morbidities associated with new public-works/manufacturing/energy projects. Some
ACOs like Kaiser are interested in utilizing these environmental models to predict rates of asthma, heatstroke,
and other CV conditions. With some additional controls, techniques, and data to improve the accuracy of these
models, predictive tools like these may be useful when predicting burden on facilities and local staff and
during ‘spikes’ in demand, to prevent short Medical staff shortages and facility overflow; they are not merely
limited to higher level policy decisions.
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Appendix

Appendix Figure A: Air Quality Measurements against Transformed Spending
Above two rows: Square Root of Weekly Cost per capita (Blue) against pm2.5 weekly
averages. Bottom two Rows: same outcome, but against mean ozone readings (red). For
briefness, only included sites 1 and 4.

